To treat relapsed or refractory mantle cell lymphoma in Grownups who may have experienced no less than two traces of systemic therapy, like a BTK inhibitor Substances for which a petition has been submitted but denied on account of insufficient proof of basic safety. Substances Within this group are https://jenningsk358qlj7.wikinewspaper.com/user